|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Banno K, Iida M, Yanokura M, Kisu I, Iwata
T, Tominaga E, Tanaka K and Aoki D: MicroRNA in cervical cancer:
OncomiRs and tumor suppressor miRs in diagnosis and treatment.
ScientificWorldJournal 2014. 1780752014.
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Handler AS, Henderson VA, Rosenfeld A,
Rankin K, Jones B and Issel LM: Illinois breast and cervical cancer
program: Implementing effective public-private partnerships to
assure population health. J Public Health Manag Pract. 21:459–466.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kogo R, How C, Chaudary N, Bruce J, Shi W,
Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin
axis regulates migration, invasion, and lymph node metastasis in
cervical cancer. Oncotarget. 6:1090–1100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:D140–D144. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shu L, Zhang Z and Cai Y: MicroRNA-204
inhibits cell migration and invasion in human cervical cancer by
regulating transcription factor 12. Oncol Lett. 15:161–166.
2018.PubMed/NCBI
|
|
8
|
Srivastava SK, Ahmad A, Zubair H, Miree O,
Singh S, Rocconi RP, Scalici J and Singh AP: MicroRNAs in
gynecological cancers: Small molecules with big implications.
Cancer Lett. 407:123–138. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Y, Liu X and Lu YX: MicroRNA-143
regulates the proliferation and apoptosis of cervical cancer cells
by targeting HIF-1alpha. Eur Rev Med Pharmacol Sci. 21:5580–5586.
2017.PubMed/NCBI
|
|
10
|
Zhang H, Lu Y, Wang S, Sheng X and Zhang
S: MicroRNA-152 acts as a tumor suppressor microRNA by inhibiting
Kruppel-like factor 5 in human cervical cancer. Oncol Res.
27:335–340. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gong M, Chen C, Zhao H, Sun M and Song M:
miR-506 suppresses cervical cancer cell proliferation both in vitro
and in vivo. Neoplasma. 65:331–338. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Z, Wang J, Wang X, Song W, Shi Y and
Zhang L: MicroRNA-21 promotes proliferation, migration, and
invasion of cervical cancer through targeting TIMP3. Arch Gynecol
Obstet. 297:433–442. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu LM, Wang WW, Qi R, Leng TG and Zhang
XL: MicroRNA-224 inhibition prevents progression of cervical
carcinoma by targeting PTX3. J Cell Biochem. 119:10278–10290. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Z, Zhang M, Qiao Y, Yang J and Yin Q:
MicroRNA-1297 contributes to the progression of human cervical
carcinoma through PTEN. Artif Cells Nanomed Biotechnol. 46 (Suppl
2):S1120–S1126. 2018. View Article : Google Scholar
|
|
15
|
Kanekura K, Nishi H, Isaka K and Kuroda M:
MicroRNA and gynecologic cancers. J Obstet Gynaecol Res.
42:612–617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gonzalez-Quintana V, Palma-Berré L,
Campos-Parra AD, López-Urrutia E, Peralta-Zaragoza O, Vazquez-Romo
R and Pérez-Plasencia C: MicroRNAs are involved in cervical cancer
development, progression, clinical outcome and improvement
treatment response (Review). Oncol Rep. 35:3–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang F, Li B and Xie X: The roles and
clinical significance of microRNAs in cervical cancer. Histol
Histopathol. 31:131–139. 2016.PubMed/NCBI
|
|
18
|
Chen L, Kong G, Zhang C, Dong H, Yang C,
Song G, Guo C, Wang L and Yu H: MicroRNA-432 functions as a tumor
suppressor gene through targeting E2F3 and AXL in lung
adenocarcinoma. Oncotarget. 7:20041–20053. 2016.PubMed/NCBI
|
|
19
|
Das E and Bhattacharyya NP: MicroRNA-432
contributes to dopamine cocktail and retinoic acid induced
differentiation of human neuroblastoma cells by targeting NESTIN
and RCOR1 genes. FEBS Lett. 588:1706–1714. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC,
Zhang T, Li Y and Wang GY: Downregulation of miR-432 activates
Wnt/beta-catenin signaling and promotes human hepatocellular
carcinoma proliferation. Oncotarget. 6:7866–7879. 2015.PubMed/NCBI
|
|
21
|
Li JB, Liu F, Zhang BP, Bai WK, Cheng W,
Zhang YH and Yu LJ: LncRNA625 modulates prostate cancer cells
proliferation and apoptosis through regulating the Wnt/beta-catenin
pathway by targeting miR-432. Eur Rev Med Pharmacol Sci.
21:2586–2595. 2017.PubMed/NCBI
|
|
22
|
Guo L, Liu X, Wang L, Sun H, Huang K, Li
X, Tang F, Li S, Yuan X and Wang C: Outcome of international
Federation of gynecology and obstetrics stage IIb cervical cancer
from 2003 to 2012: An evaluation of treatments and prognosis: A
retrospective study. Int J Gynecol Cancer. 25:910–918. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai X, Liu C, Zhang TN, Zhu YW, Dong X and
Xue P: Down-regulation of FN1 inhibits colorectal carcinogenesis by
suppressing proliferation, migration, and invasion. J Cell Biochem.
119:4717–4728. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ye Y, Zhuang J, Wang G, He S, Ni J and Xia
W: MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid
carcinoma progression. Oncol Lett. 14:7799–7806. 2017.PubMed/NCBI
|
|
26
|
Wang J, Deng L, Huang J, Cai R, Zhu X, Liu
F, Wang Q, Zhang J and Zheng Y: High expression of Fibronectin 1
suppresses apoptosis through the NF-κB pathway and is associated
with migration in nasopharyngeal carcinoma. Am J Transl Res.
9:4502–4511. 2017.PubMed/NCBI
|
|
27
|
Xu X, Liu Z, Zhou L, Xie H, Cheng J, Ling
Q, Wang J, Guo H, Wei X and Zheng S: Characterization of
genome-wide TFCP2 targets in hepatocellular carcinoma: Implication
of targets FN1 and TJP1 in metastasis. J Exp Clin Cancer Res.
34:62015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Diaz-Gonzalez Sdel M, Deas J,
Benitez-Boijseauneau O, Gómez-Cerón C, Bermúdez-Morales VH,
Rodríguez-Dorantes M, Pérez-Plasencia C and Peralta-Zaragoza O:
Utility of microRNAs and siRNAs in cervical carcinogenesis. Biomed
Res Int 2015. 3749242015.
|
|
29
|
Yang F, Guo L, Cao Y, Li S, Li J and Liu
M: MicroRNA-7-5p promotes cisplatin resistance of cervical cancer
cells and modulation of cellular energy homeostasis by regulating
the expression of the PARP-1 and BCL2 genes. Med Sci Monit.
24:6506–6516. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shang A, Zhou C, Bian G, Chen W, Lu W,
Wang W and Li D: miR-381-3p restrains cervical cancer progression
by downregulating FGF7. J Cell Biochem. 120:778–789. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ruiz-Garcia E, Scott V, Machavoine C,
Bidart JM, Lacroix L, Delaloge S and Andre F: Gene expression
profiling identifies Fibronectin 1 and CXCL9 as candidate
biomarkers for breast cancer screening. Br J Cancer. 102:462–468.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang H, Sun Z, Li Y, Fan D and Jiang H:
MicroRNA-200c binding to FN1 suppresses the proliferation,
migration and invasion of gastric cancer cells. Biomed
Pharmacother. 88:285–292. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Helleman J, Jansen MP, Span PN, van
Staveren IL, Massuger LF, Meijer-van Gelder ME, Sweep FC, Ewing PC,
van der Burg ME, Stoter G, et al: Molecular profiling of platinum
resistant ovarian cancer. Int J Cancer. 118:1963–1971. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sponziello M, Rosignolo F, Celano M,
Maggisano V, Pecce V, De Rose RF, Lombardo GE, Durante C, Filetti
S, Damante G, et al: Fibronectin-1 expression is increased in
aggressive thyroid cancer and favors the migration and invasion of
cancer cells. Mol Cell Endocrinol. 431:123–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
